Company profileNutraceutical & supplements#1147 of 1,318 in Pakistan✓ No DRAP alerts

Kobec Opthal

Nutraceutical & supplement manufacturer · 1 registered products

Ranked #18 of 23 companies in Eye Conditions

1 registered products 3 distinct molecules 0 DRAP alerts
1 of this company's registrations sit in the DRAP category “Eye”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

1
registered products
3
distinct molecules
1
therapeutic classes
0
DRAP alerts

Kobec Opthal is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 1 product registration. Its portfolio is concentrated in Eye Conditions. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Kobec

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Eye1 brand
Dextran1 brand

Therapeutic classes

Eye Conditions · 1

Conditions treated

Dry Eye/Allergy · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 325 – Rs 325
Servaid1 products · Rs 206.99 – Rs 206.99
Median across source: Rs 325

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Sante (Private) Limited2 shared molecules
MACQUINS INTERNATIONAL2 shared molecules
Alcon2 shared molecules
Otsuka Pakistan Limited1 shared molecules
S. EJAZUDDIN & COMPANY1 shared molecules
SEARLE IV SOLUTION1 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Sante (Private) Limited holds 78 molecules not in this portfolio
AcyclovirAmlodipineArtemetherAzithromycinAzithromycin Azithromycin DihydarteBenzoyl Peroxide
Alcon holds 12 molecules not in this portfolio
BetaxololCiprofloxacinCyclopentolateDexamethasoneEmedastineMoxifloxacin

Get the full profile for Kobec

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.